ClinicalTrials.gg
Sign In

DrugBiological

Palverafusp alfa clinical trials

Also written IMM2510.

studies test it
4
open now
4
in phase 3
0
first study started
2021

Keep track of what changes. Save the palverafusp alfa studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.

Watch these studies

How studies write it

Studies that test it under each name

Development codes

IMM2510
3

Studies by the year they started

4 studies that test it; most in 2021 (1)

Studies that test palverafusp alfa, by start year
YearStudies
20211
20241
20251
20261

By phase

A phase 1/2 study counts in both.

Phase 1
3
Phase 2
2

What it is tested for

Each study’s main condition, where its own words name it.

Neoplasms
2
Carcinoma, Hepatocellular
1

Who runs them

Industry 0 · Other 4

ImmuneOnco Biopharmaceuticals (Shanghai) Inc. (4)

Often tested with

Tested in the same studies.

Timdarpacept (1) · IMM27M (1)

Studies

Open first, then newest update. How each study uses palverafusp alfa is read from its arms, and is right about nine times in ten.

Testing it · 4

Given in every arm · 1 — palverafusp alfa is usual care beside what is tested

Codes

What other systems call palverafusp alfa · ClinicalTrials.gg INT014689

  • UNII (FDA) 3K7FU8FR2JPALVERAFUSP ALFAOne source FDA
  • NCI Thesaurus C206964Palverafusp AlfaOne source FDA

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.